Duration of untreated psychosis: a critical examination of the concept and its importance

Background. The concept of duration of untreated psychosis (DUP) has recently attracted much interest because of its possible relationship to treatment outcome and implications for preventive efforts with reference to psychotic disorders, especially schizophrenia. In this paper we review critically the literature concerning the concept and its importance. Methods. Articles concerned with measuring DUP and those that have been suggested to provide indirect or direct evidence of the effect of DUP on treatment outcome are reviewed. Results. Evidence thus far suggests that DUP may be related to ease of reducing psychotic symptoms once treatment begins for first episode patients, but there is no evidence of a relationship to likelihood of relapse. There has been little investigation of the relationship of DUP to other long-term outcomes such as negative symptoms and cognitive functioning neither have the possible confounds of DUP been widely investigated or controlled. Conclusions. It is important that there should be more thorough investigations of DUP, its correlates, and the extent to which it does mediate any advantages of earlier intervention.

[1]  N C Andreasen,et al.  Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. , 2000, The American journal of psychiatry.

[2]  M. Clarke,et al.  Determinants of quality of life at first presentation with schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.

[3]  M Cortsen,et al.  Progressive atrophy of the frontal lobes in first‐episode schizophrenia: interaction with clinical course and neuroleptic treatment , 1999, Acta psychiatrica Scandinavica.

[4]  M. Keshavan Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. , 1999, Journal of psychiatric research.

[5]  P. McGorry,et al.  Duration of untreated psychosis and 12‐month outcome in first‐episode psychosis: the impact of treatment approach , 1999, Acta psychiatrica Scandinavica.

[6]  J. Lieberman,et al.  Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. , 1999, The American journal of psychiatry.

[7]  A. Malla,et al.  Improving outcome in schizophrenia: the case for early intervention. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  J. Lieberman,et al.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. , 1999, Archives of general psychiatry.

[9]  D. Streiner,et al.  Confronting the Confounders: The Meaning, Detection, and Treatment of Confounders in Research , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[10]  C. Glazebrook,et al.  Prevalence of substance misuse in first-episode psychosis , 1999, British Journal of Psychiatry.

[11]  J. Os,et al.  Prediction of duration of psychosis before first admission , 1998, European Psychiatry.

[12]  D. Linszen,et al.  Early intervention, untreated psychosis and the course of early schizophrenia , 1998, British Journal of Psychiatry.

[13]  P. McGorry,et al.  Prolonged recovery in first-episode psychosis , 1998, British Journal of Psychiatry.

[14]  J. O. Johannessen,et al.  First-episode schizophrenia with long duration of untreated psychosis: Pathways to care , 1998, British Journal of Psychiatry.

[15]  J. Sweeney,et al.  Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. , 1998, Journal of psychiatric research.

[16]  J. Dequardo Pharmacologic treatment of first-episode schizophrenia: early intervention is key to outcome. , 1998, The Journal of clinical psychiatry.

[17]  M. Birchwood,et al.  Early intervention in psychosis: the critical‐period hypothesis , 1998, British Journal of Psychiatry.

[18]  J. Waddington,et al.  Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia , 1997, Psychological Medicine.

[19]  Jeffrey A Lieberman,et al.  Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity , 1997, Neuropsychopharmacology.

[20]  G. Haas,et al.  Hopelessness and first‐episode psychosis: a longitudinal study , 1997, Acta psychiatrica Scandinavica.

[21]  J. Ragland,et al.  Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study , 1997, Schizophrenia Research.

[22]  R. Wyatt,et al.  Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data , 1997, Psychological Medicine.

[23]  P. Williamson,et al.  Neuropsychological correlates of syndromes in schizophrenia , 1997, British Journal of Psychiatry.

[24]  N. Andreasen,et al.  The Iowa Longitudinal Study of Recent Onset Psychosis: One-year follow-up of first episode patients , 1997, Schizophrenia Research.

[25]  Tyrone D. Cannon,et al.  Course of treatment response in first-episode and chronic schizophrenia. , 1996, The American journal of psychiatry.

[26]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[27]  J. Waddington,et al.  Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia , 1995, Psychological Medicine.

[28]  A. Riecher-Rössler,et al.  The Influence of Age and Sex on the Onset and Early Course of Schizophrenia , 1993, British Journal of Psychiatry.

[29]  J. Lieberman,et al.  Duration of psychosis and outcome in first-episode schizophrenia. , 1992, The American journal of psychiatry.

[30]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[31]  H. Y. Meltzer Dimensions of Outcome with Clozapine , 1992, British Journal of Psychiatry.

[32]  A. Riecher-Rössler,et al.  IRAOS: an instrument for the assessment of onset and early course of schizophrenia , 1992, Schizophrenia Research.

[33]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[34]  D. Pickar,et al.  National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. , 1991, Archives of general psychiatry.

[35]  L. Helgason Twenty years’ follow‐up of first psychiatric presentation for schizophrenia: what could have been prevented? , 1990, Acta psychiatrica Scandinavica.

[36]  J. Kane,et al.  Outcome study of first-episode psychosis. I: Relapse rates after 1 year. , 1986, The American journal of psychiatry.

[37]  M. Shepherd,et al.  The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment , 1983, Psychological Medicine.

[38]  D. A. Johnson,et al.  The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences , 1983, Acta psychiatrica Scandinavica.

[39]  W. Dixon,et al.  Schizophrenia. A follow-up study of the results of five forms of treatment. , 1981, Archives of General Psychiatry.

[40]  A. Jablensky,et al.  WHO collaborative study on impairments and disabilities associated with schizophrenic disorders , 1980 .

[41]  W. Lo,et al.  A Ten-Year Follow-up Study of Chinese Schizophrenics in Hong Kong , 1977, British Journal of Psychiatry.

[42]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[43]  W. Dixon,et al.  Schizophrenia--a follow-up study of results of treatment. , 1976, Archives of general psychiatry.

[44]  S. Hirsch,et al.  Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo , 1973, British medical journal.

[45]  F. Freyhan Prognosis of Schizophrenia Before and After Pharmacotherapy , 1968, British Journal of Psychiatry.

[46]  M. Pritchard Prognosis of Schizophrenia Before and After Pharmacotherapy: II. Three-Year Follow-Up , 1967, British Journal of Psychiatry.

[47]  M. Pritchard Prognosis of Schizophrenia Before and After Pharmacotherapy: I. Short Term Outcome , 1967, British Journal of Psychiatry.

[48]  M. Markowe,et al.  Insulin and Chlorpromazine in Schizophrenia: A Ten Year Comparative Survey , 1967, British Journal of Psychiatry.

[49]  N. Schooler,et al.  One year after discharge: community adjustment of schizophrenic patients. , 1967, The American journal of psychiatry.

[50]  R. D. Wirt,et al.  LONG-TERM FOLLOW-UP STUDY OF SCHIZOPHRENIC PATIENTS. , 1965, Archives of general psychiatry.

[51]  G. Olson,et al.  FIRST ADMITTED SCHIZOPHRENICS IN DRUG ERA; FOLLOW-UP ANOKA SCHIZOPHRENIC COHORT, 1956-1958. , 1964, Archives of general psychiatry.

[52]  O. Odegard PATTERN OF DISCHARGE FROM NORWEGIAN PSYCHIATRIC HOSPITALS BEFORE AND AFTER THE INTRODUCTION OF THE PSYCHOTROPIC DRUGS. , 1964, The American journal of psychiatry.

[53]  A. Watt,et al.  OUTCOMES OF TREATMENT OF SCHIZOPHRENIA IN A NORTH-EAST SCOTTISH MENTAL HOSPITAL , 1961 .

[54]  E. Bromet,et al.  Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? , 2000, The American journal of psychiatry.

[55]  J. Jo Early intervention and prevention in schizophrenia--experiences from a study in Stavanger, Norway. , 1998 .

[56]  W. Iacono,et al.  Social support predicts 5-year outcome in first-episode schizophrenia. , 1998, Journal of abnormal psychology.

[57]  J. O. Johannessen Early intervention and prevention in schizophrenia--experiences from a study in Stavanger, Norway. , 1998, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[58]  R Giel,et al.  Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. , 1998, Schizophrenia bulletin.

[59]  R. Bjorklund First person account: psychosocial implications of stigma caused by misdiagnosis. , 1998, Schizophrenia bulletin.

[60]  C. Mihalopoulos,et al.  EPPIC: an evolving system of early detection and optimal management. , 1996, Schizophrenia bulletin.

[61]  T. McGlashan,et al.  First-episode schizophrenia: I. Early course parameters. , 1996, Schizophrenia bulletin.

[62]  R. Kydd,et al.  Early detection and intervention for initial episodes of schizophrenia. , 1996, Schizophrenia bulletin.

[63]  T. McGlashan,et al.  Early detection and intervention in schizophrenia: research. , 1996, Schizophrenia bulletin.

[64]  J. O. Johannessen,et al.  Early detection and intervention with schizophrenia: rationale. , 1996, Schizophrenia bulletin.

[65]  P. Vaglum Earlier detection and intervention in schizophrenia: unsolved questions. , 1996, Schizophrenia bulletin.

[66]  E. Laska,et al.  Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. , 1996, Social psychiatry and psychiatric epidemiology.

[67]  W. Iacono,et al.  Establishing the onset of psychotic illness. , 1993, The American journal of psychiatry.

[68]  A. Stoll,et al.  The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. , 1992, Schizophrenia bulletin.

[69]  J. Sweeney,et al.  Premorbid and onset features of first-episode schizophrenia. , 1992, Schizophrenia bulletin.

[70]  J. Lieberman,et al.  Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. , 1992, Schizophrenia bulletin.

[71]  Tyrone D. Cannon,et al.  Phenomenology and functioning in first-episode schizophrenia. , 1992, Schizophrenia bulletin.

[72]  R J Wyatt,et al.  Neuroleptics and the natural course of schizophrenia. , 1991, Schizophrenia bulletin.

[73]  D. Copolov,et al.  Royal Park Multidiagnostic Instrument for Psychosis: Part II. Development, reliability, and validity. , 1990, Schizophrenia bulletin.

[74]  W. Iacono,et al.  The role of social relationships in the course of first-episode schizophrenia and affective psychosis. , 1989, The American journal of psychiatry.

[75]  R. Bilder,et al.  Symptomatic and neuropsychological components of defect states. , 1985, Schizophrenia bulletin.

[76]  W T Carpenter,et al.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.

[77]  有留 照周 A study on the long-term prognosis of schizophrenia under psychotropic drug medication , 1979 .

[78]  M. Rappaport,et al.  Are there schizophrenics for whom drugs may be unnecessary or contraindicated? , 1978, International pharmacopsychiatry.

[79]  T. McGlashan,et al.  The treatment of acute schizophrenia without drugs: an investigation of some current assumptions. , 1977, The American journal of psychiatry.

[80]  K. Achté On prognosis and rehabilitation in schizophrenic and paranoid psychoses. A comparative follow-up study of two series of patients first admitted to hospital in 1950 and 1960 respectively. , 1967, Acta psychiatrica Scandinavica. Supplementum.

[81]  M. Opler,et al.  Drug and social therapy in chronic schizophrenia , 1966 .